chr9-21206984-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002171.2(IFNA10):c.114G>T(p.Leu38Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000998 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002171.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFNA10 | NM_002171.2 | c.114G>T | p.Leu38Phe | missense_variant | 1/1 | ENST00000357374.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFNA10 | ENST00000357374.2 | c.114G>T | p.Leu38Phe | missense_variant | 1/1 | NM_002171.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000448 AC: 68AN: 151932Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251122Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135798
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1461838Hom.: 0 Cov.: 33 AF XY: 0.0000550 AC XY: 40AN XY: 727218
GnomAD4 genome AF: 0.000460 AC: 70AN: 152052Hom.: 0 Cov.: 31 AF XY: 0.000551 AC XY: 41AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.114G>T (p.L38F) alteration is located in exon 1 (coding exon 1) of the IFNA10 gene. This alteration results from a G to T substitution at nucleotide position 114, causing the leucine (L) at amino acid position 38 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at